Cargando...
Bumetanide for autism: Open‐label trial in six children
AIM: Bumetanide, a diuretic agent, that reduces intracellular chloride—thereby reinforcing GABAergic inhibition—has been reported to improve core symptoms of autism in children. Given the positive results reported from French trials of bumetanide in children with autism, we decided to evaluate its e...
Guardado en:
| Publicado en: | Acta Paediatr |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248373/ https://ncbi.nlm.nih.gov/pubmed/33336381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apa.15723 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|